nodes	percent_of_prediction	percent_of_DWPC	metapath
Candesartan—ABCB1—ovarian cancer	0.476	1	CbGaD
Candesartan—ABCB1—Topotecan—ovarian cancer	0.0675	0.246	CbGbCtD
Candesartan—CYP2C8—Paclitaxel—ovarian cancer	0.0494	0.18	CbGbCtD
Candesartan—ABCB1—Vinorelbine—ovarian cancer	0.0476	0.173	CbGbCtD
Candesartan—CYP2C9—Paclitaxel—ovarian cancer	0.0344	0.125	CbGbCtD
Candesartan—ABCB1—Paclitaxel—ovarian cancer	0.0334	0.122	CbGbCtD
Candesartan—ABCB1—Docetaxel—ovarian cancer	0.0242	0.088	CbGbCtD
Candesartan—ABCB1—Doxorubicin—ovarian cancer	0.018	0.0656	CbGbCtD
Candesartan—PTGS1—oviduct—ovarian cancer	0.00321	0.107	CbGeAlD
Candesartan—AGTR1—myometrium—ovarian cancer	0.00234	0.0776	CbGeAlD
Candesartan—AGTR1—epithelium—ovarian cancer	0.00183	0.0609	CbGeAlD
Candesartan—AGTR1—uterine cervix—ovarian cancer	0.00182	0.0604	CbGeAlD
Candesartan—AGTR1—decidua—ovarian cancer	0.00173	0.0575	CbGeAlD
Candesartan—AGTR1—female reproductive system—ovarian cancer	0.00136	0.0452	CbGeAlD
Candesartan—AGTR1—vagina—ovarian cancer	0.00123	0.0409	CbGeAlD
Candesartan—AGTR1—testis—ovarian cancer	0.0011	0.0365	CbGeAlD
Candesartan—CYP2C8—endometrium—ovarian cancer	0.000892	0.0296	CbGeAlD
Candesartan—PTGS1—epithelium—ovarian cancer	0.000807	0.0268	CbGeAlD
Candesartan—PTGS1—uterine cervix—ovarian cancer	0.0008	0.0265	CbGeAlD
Candesartan—AGTR1—lymph node—ovarian cancer	0.000797	0.0265	CbGeAlD
Candesartan—CYP2C8—female reproductive system—ovarian cancer	0.000739	0.0245	CbGeAlD
Candesartan—PTGS1—endometrium—ovarian cancer	0.000723	0.024	CbGeAlD
Candesartan—CYP2C8—vagina—ovarian cancer	0.000668	0.0222	CbGeAlD
Candesartan—PTGS1—uterus—ovarian cancer	0.000667	0.0221	CbGeAlD
Candesartan—CYP2C9—female reproductive system—ovarian cancer	0.000656	0.0218	CbGeAlD
Candesartan—ABCB1—myometrium—ovarian cancer	0.000608	0.0202	CbGeAlD
Candesartan—PTGS1—female reproductive system—ovarian cancer	0.000599	0.0199	CbGeAlD
Candesartan—CYP2C8—testis—ovarian cancer	0.000596	0.0198	CbGeAlD
Candesartan—ABCB1—embryo—ovarian cancer	0.000584	0.0194	CbGeAlD
Candesartan—PTGS1—female gonad—ovarian cancer	0.000545	0.0181	CbGeAlD
Candesartan—PTGS1—vagina—ovarian cancer	0.000542	0.018	CbGeAlD
Candesartan—Urinary tract disorder—Paclitaxel—ovarian cancer	0.000515	0.00236	CcSEcCtD
Candesartan—Hypotension—Vinorelbine—ovarian cancer	0.000515	0.00236	CcSEcCtD
Candesartan—Oedema peripheral—Paclitaxel—ovarian cancer	0.000514	0.00236	CcSEcCtD
Candesartan—Pruritus—Chlorambucil—ovarian cancer	0.000512	0.00235	CcSEcCtD
Candesartan—Urticaria—Topotecan—ovarian cancer	0.000512	0.00235	CcSEcCtD
Candesartan—Urethral disorder—Paclitaxel—ovarian cancer	0.000511	0.00234	CcSEcCtD
Candesartan—Body temperature increased—Topotecan—ovarian cancer	0.000509	0.00233	CcSEcCtD
Candesartan—Abdominal pain—Topotecan—ovarian cancer	0.000509	0.00233	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.000502	0.0023	CcSEcCtD
Candesartan—Urticaria—Melphalan—ovarian cancer	0.000501	0.0023	CcSEcCtD
Candesartan—Diarrhoea—Chlorambucil—ovarian cancer	0.000495	0.00227	CcSEcCtD
Candesartan—Paraesthesia—Vinorelbine—ovarian cancer	0.000495	0.00227	CcSEcCtD
Candesartan—Dyspnoea—Vinorelbine—ovarian cancer	0.000491	0.00225	CcSEcCtD
Candesartan—Acute coronary syndrome—Docetaxel—ovarian cancer	0.000486	0.00223	CcSEcCtD
Candesartan—Renal failure—Docetaxel—ovarian cancer	0.000484	0.00222	CcSEcCtD
Candesartan—PTGS1—testis—ovarian cancer	0.000484	0.016	CbGeAlD
Candesartan—Myocardial infarction—Docetaxel—ovarian cancer	0.000483	0.00221	CcSEcCtD
Candesartan—ABCB1—epithelium—ovarian cancer	0.000477	0.0158	CbGeAlD
Candesartan—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000476	0.00218	CcSEcCtD
Candesartan—Cardiac failure congestive—Epirubicin—ovarian cancer	0.000475	0.00218	CcSEcCtD
Candesartan—Fatigue—Vinorelbine—ovarian cancer	0.000475	0.00218	CcSEcCtD
Candesartan—ABCB1—uterine cervix—ovarian cancer	0.000473	0.0157	CbGeAlD
Candesartan—Epistaxis—Docetaxel—ovarian cancer	0.000465	0.00213	CcSEcCtD
Candesartan—Asthenia—Topotecan—ovarian cancer	0.000462	0.00212	CcSEcCtD
Candesartan—Vomiting—Chlorambucil—ovarian cancer	0.00046	0.00211	CcSEcCtD
Candesartan—Agranulocytosis—Docetaxel—ovarian cancer	0.00046	0.00211	CcSEcCtD
Candesartan—Mental disorder—Paclitaxel—ovarian cancer	0.000457	0.0021	CcSEcCtD
Candesartan—Pruritus—Topotecan—ovarian cancer	0.000456	0.00209	CcSEcCtD
Candesartan—Malnutrition—Paclitaxel—ovarian cancer	0.000454	0.00208	CcSEcCtD
Candesartan—Renal impairment—Epirubicin—ovarian cancer	0.000453	0.00208	CcSEcCtD
Candesartan—Asthenia—Melphalan—ovarian cancer	0.000453	0.00207	CcSEcCtD
Candesartan—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000451	0.00207	CcSEcCtD
Candesartan—ABCB1—decidua—ovarian cancer	0.000451	0.015	CbGeAlD
Candesartan—Pruritus—Melphalan—ovarian cancer	0.000446	0.00205	CcSEcCtD
Candesartan—Haemoglobin—Docetaxel—ovarian cancer	0.000444	0.00204	CcSEcCtD
Candesartan—Rhinitis—Docetaxel—ovarian cancer	0.000443	0.00203	CcSEcCtD
Candesartan—Haemorrhage—Docetaxel—ovarian cancer	0.000442	0.00203	CcSEcCtD
Candesartan—Hepatitis—Docetaxel—ovarian cancer	0.000442	0.00203	CcSEcCtD
Candesartan—Cardiac failure—Epirubicin—ovarian cancer	0.000442	0.00203	CcSEcCtD
Candesartan—Diarrhoea—Topotecan—ovarian cancer	0.000441	0.00202	CcSEcCtD
Candesartan—Cardiac failure congestive—Doxorubicin—ovarian cancer	0.00044	0.00202	CcSEcCtD
Candesartan—Back pain—Paclitaxel—ovarian cancer	0.000439	0.00201	CcSEcCtD
Candesartan—Pharyngitis—Docetaxel—ovarian cancer	0.000439	0.00201	CcSEcCtD
Candesartan—Urticaria—Vinorelbine—ovarian cancer	0.000438	0.00201	CcSEcCtD
Candesartan—Urinary tract disorder—Docetaxel—ovarian cancer	0.000437	0.002	CcSEcCtD
Candesartan—Body temperature increased—Vinorelbine—ovarian cancer	0.000436	0.002	CcSEcCtD
Candesartan—Abdominal pain—Vinorelbine—ovarian cancer	0.000436	0.002	CcSEcCtD
Candesartan—Oedema peripheral—Docetaxel—ovarian cancer	0.000436	0.002	CcSEcCtD
Candesartan—Urethral disorder—Docetaxel—ovarian cancer	0.000433	0.00199	CcSEcCtD
Candesartan—Hyponatraemia—Epirubicin—ovarian cancer	0.000433	0.00198	CcSEcCtD
Candesartan—Diarrhoea—Melphalan—ovarian cancer	0.000432	0.00198	CcSEcCtD
Candesartan—Nausea—Chlorambucil—ovarian cancer	0.00043	0.00197	CcSEcCtD
Candesartan—ABCB1—endometrium—ovarian cancer	0.000428	0.0142	CbGeAlD
Candesartan—Dizziness—Topotecan—ovarian cancer	0.000426	0.00195	CcSEcCtD
Candesartan—Anaemia—Paclitaxel—ovarian cancer	0.00042	0.00192	CcSEcCtD
Candesartan—Renal impairment—Doxorubicin—ovarian cancer	0.000419	0.00192	CcSEcCtD
Candesartan—Angioedema—Paclitaxel—ovarian cancer	0.000415	0.0019	CcSEcCtD
Candesartan—Vomiting—Topotecan—ovarian cancer	0.00041	0.00188	CcSEcCtD
Candesartan—Cardiac failure—Doxorubicin—ovarian cancer	0.000409	0.00187	CcSEcCtD
Candesartan—Vertigo—Paclitaxel—ovarian cancer	0.000408	0.00187	CcSEcCtD
Candesartan—Leukopenia—Paclitaxel—ovarian cancer	0.000407	0.00186	CcSEcCtD
Candesartan—Rash—Topotecan—ovarian cancer	0.000406	0.00186	CcSEcCtD
Candesartan—Dermatitis—Topotecan—ovarian cancer	0.000406	0.00186	CcSEcCtD
Candesartan—Blood creatinine increased—Epirubicin—ovarian cancer	0.000404	0.00185	CcSEcCtD
Candesartan—Headache—Topotecan—ovarian cancer	0.000404	0.00185	CcSEcCtD
Candesartan—Palpitations—Paclitaxel—ovarian cancer	0.000401	0.00184	CcSEcCtD
Candesartan—Vomiting—Melphalan—ovarian cancer	0.000401	0.00184	CcSEcCtD
Candesartan—Hyponatraemia—Doxorubicin—ovarian cancer	0.000401	0.00184	CcSEcCtD
Candesartan—Rash—Melphalan—ovarian cancer	0.000398	0.00182	CcSEcCtD
Candesartan—Dermatitis—Melphalan—ovarian cancer	0.000397	0.00182	CcSEcCtD
Candesartan—ABCB1—gonad—ovarian cancer	0.000397	0.0132	CbGeAlD
Candesartan—Cough—Paclitaxel—ovarian cancer	0.000396	0.00182	CcSEcCtD
Candesartan—Asthenia—Vinorelbine—ovarian cancer	0.000395	0.00181	CcSEcCtD
Candesartan—ABCB1—uterus—ovarian cancer	0.000394	0.0131	CbGeAlD
Candesartan—Hypertension—Paclitaxel—ovarian cancer	0.000392	0.0018	CcSEcCtD
Candesartan—Pruritus—Vinorelbine—ovarian cancer	0.00039	0.00179	CcSEcCtD
Candesartan—Mental disorder—Docetaxel—ovarian cancer	0.000387	0.00178	CcSEcCtD
Candesartan—Myalgia—Paclitaxel—ovarian cancer	0.000387	0.00177	CcSEcCtD
Candesartan—Chest pain—Paclitaxel—ovarian cancer	0.000387	0.00177	CcSEcCtD
Candesartan—Arthralgia—Paclitaxel—ovarian cancer	0.000387	0.00177	CcSEcCtD
Candesartan—Anxiety—Paclitaxel—ovarian cancer	0.000385	0.00177	CcSEcCtD
Candesartan—Malnutrition—Docetaxel—ovarian cancer	0.000385	0.00176	CcSEcCtD
Candesartan—Nausea—Topotecan—ovarian cancer	0.000383	0.00175	CcSEcCtD
Candesartan—Diarrhoea—Vinorelbine—ovarian cancer	0.000377	0.00173	CcSEcCtD
Candesartan—Nausea—Melphalan—ovarian cancer	0.000375	0.00172	CcSEcCtD
Candesartan—Blood creatinine increased—Doxorubicin—ovarian cancer	0.000374	0.00171	CcSEcCtD
Candesartan—Back pain—Docetaxel—ovarian cancer	0.000372	0.00171	CcSEcCtD
Candesartan—Dizziness—Vinorelbine—ovarian cancer	0.000364	0.00167	CcSEcCtD
Candesartan—Angina pectoris—Epirubicin—ovarian cancer	0.000363	0.00166	CcSEcCtD
Candesartan—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000363	0.00166	CcSEcCtD
Candesartan—Tachycardia—Paclitaxel—ovarian cancer	0.000362	0.00166	CcSEcCtD
Candesartan—Bronchitis—Epirubicin—ovarian cancer	0.000358	0.00164	CcSEcCtD
Candesartan—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000358	0.00164	CcSEcCtD
Candesartan—Anaemia—Docetaxel—ovarian cancer	0.000356	0.00163	CcSEcCtD
Candesartan—ABCB1—female reproductive system—ovarian cancer	0.000354	0.0118	CbGeAlD
Candesartan—PTGS1—lymph node—ovarian cancer	0.000351	0.0116	CbGeAlD
Candesartan—Vomiting—Vinorelbine—ovarian cancer	0.00035	0.00161	CcSEcCtD
Candesartan—Neutropenia—Epirubicin—ovarian cancer	0.000348	0.0016	CcSEcCtD
Candesartan—Rash—Vinorelbine—ovarian cancer	0.000347	0.00159	CcSEcCtD
Candesartan—Dermatitis—Vinorelbine—ovarian cancer	0.000347	0.00159	CcSEcCtD
Candesartan—Hypotension—Paclitaxel—ovarian cancer	0.000346	0.00159	CcSEcCtD
Candesartan—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000346	0.00159	CcSEcCtD
Candesartan—Headache—Vinorelbine—ovarian cancer	0.000345	0.00158	CcSEcCtD
Candesartan—Leukopenia—Docetaxel—ovarian cancer	0.000345	0.00158	CcSEcCtD
Candesartan—Palpitations—Docetaxel—ovarian cancer	0.00034	0.00156	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000338	0.00155	CcSEcCtD
Candesartan—Hyperglycaemia—Epirubicin—ovarian cancer	0.000336	0.00154	CcSEcCtD
Candesartan—Cough—Docetaxel—ovarian cancer	0.000336	0.00154	CcSEcCtD
Candesartan—Angina pectoris—Doxorubicin—ovarian cancer	0.000336	0.00154	CcSEcCtD
Candesartan—ABCB1—bone marrow—ovarian cancer	0.000334	0.0111	CbGeAlD
Candesartan—Paraesthesia—Paclitaxel—ovarian cancer	0.000333	0.00153	CcSEcCtD
Candesartan—Hypertension—Docetaxel—ovarian cancer	0.000332	0.00152	CcSEcCtD
Candesartan—Bronchitis—Doxorubicin—ovarian cancer	0.000332	0.00152	CcSEcCtD
Candesartan—Dyspnoea—Paclitaxel—ovarian cancer	0.00033	0.00151	CcSEcCtD
Candesartan—Somnolence—Paclitaxel—ovarian cancer	0.00033	0.00151	CcSEcCtD
Candesartan—Myalgia—Docetaxel—ovarian cancer	0.000328	0.0015	CcSEcCtD
Candesartan—Arthralgia—Docetaxel—ovarian cancer	0.000328	0.0015	CcSEcCtD
Candesartan—Chest pain—Docetaxel—ovarian cancer	0.000328	0.0015	CcSEcCtD
Candesartan—Nausea—Vinorelbine—ovarian cancer	0.000327	0.0015	CcSEcCtD
Candesartan—Renal failure—Epirubicin—ovarian cancer	0.000327	0.0015	CcSEcCtD
Candesartan—Dyspepsia—Paclitaxel—ovarian cancer	0.000326	0.0015	CcSEcCtD
Candesartan—Neutropenia—Doxorubicin—ovarian cancer	0.000322	0.00148	CcSEcCtD
Candesartan—ABCB1—female gonad—ovarian cancer	0.000322	0.0107	CbGeAlD
Candesartan—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.00032	0.00147	CcSEcCtD
Candesartan—ABCB1—vagina—ovarian cancer	0.00032	0.0106	CbGeAlD
Candesartan—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00032	0.00147	CcSEcCtD
Candesartan—Fatigue—Paclitaxel—ovarian cancer	0.00032	0.00146	CcSEcCtD
Candesartan—Haematuria—Epirubicin—ovarian cancer	0.000317	0.00145	CcSEcCtD
Candesartan—Epistaxis—Epirubicin—ovarian cancer	0.000313	0.00144	CcSEcCtD
Candesartan—Sinusitis—Epirubicin—ovarian cancer	0.000312	0.00143	CcSEcCtD
Candesartan—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000311	0.00143	CcSEcCtD
Candesartan—Agranulocytosis—Epirubicin—ovarian cancer	0.00031	0.00142	CcSEcCtD
Candesartan—Thrombocytopenia—Docetaxel—ovarian cancer	0.000308	0.00141	CcSEcCtD
Candesartan—Tachycardia—Docetaxel—ovarian cancer	0.000307	0.00141	CcSEcCtD
Candesartan—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000303	0.00139	CcSEcCtD
Candesartan—Renal failure—Doxorubicin—ovarian cancer	0.000302	0.00139	CcSEcCtD
Candesartan—Haemoglobin—Epirubicin—ovarian cancer	0.0003	0.00137	CcSEcCtD
Candesartan—Rhinitis—Epirubicin—ovarian cancer	0.000299	0.00137	CcSEcCtD
Candesartan—Haemorrhage—Epirubicin—ovarian cancer	0.000298	0.00137	CcSEcCtD
Candesartan—Hepatitis—Epirubicin—ovarian cancer	0.000298	0.00137	CcSEcCtD
Candesartan—Pharyngitis—Epirubicin—ovarian cancer	0.000296	0.00136	CcSEcCtD
Candesartan—Urinary tract disorder—Epirubicin—ovarian cancer	0.000295	0.00135	CcSEcCtD
Candesartan—Urticaria—Paclitaxel—ovarian cancer	0.000294	0.00135	CcSEcCtD
Candesartan—Oedema peripheral—Epirubicin—ovarian cancer	0.000294	0.00135	CcSEcCtD
Candesartan—Hypotension—Docetaxel—ovarian cancer	0.000294	0.00135	CcSEcCtD
Candesartan—Haematuria—Doxorubicin—ovarian cancer	0.000293	0.00134	CcSEcCtD
Candesartan—Abdominal pain—Paclitaxel—ovarian cancer	0.000293	0.00134	CcSEcCtD
Candesartan—Body temperature increased—Paclitaxel—ovarian cancer	0.000293	0.00134	CcSEcCtD
Candesartan—Urethral disorder—Epirubicin—ovarian cancer	0.000292	0.00134	CcSEcCtD
Candesartan—Epistaxis—Doxorubicin—ovarian cancer	0.00029	0.00133	CcSEcCtD
Candesartan—Sinusitis—Doxorubicin—ovarian cancer	0.000288	0.00132	CcSEcCtD
Candesartan—Agranulocytosis—Doxorubicin—ovarian cancer	0.000287	0.00132	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000286	0.00131	CcSEcCtD
Candesartan—ABCB1—testis—ovarian cancer	0.000286	0.00949	CbGeAlD
Candesartan—Paraesthesia—Docetaxel—ovarian cancer	0.000282	0.00129	CcSEcCtD
Candesartan—Dyspnoea—Docetaxel—ovarian cancer	0.00028	0.00128	CcSEcCtD
Candesartan—Somnolence—Docetaxel—ovarian cancer	0.000279	0.00128	CcSEcCtD
Candesartan—Haemoglobin—Doxorubicin—ovarian cancer	0.000277	0.00127	CcSEcCtD
Candesartan—Rhinitis—Doxorubicin—ovarian cancer	0.000277	0.00127	CcSEcCtD
Candesartan—Dyspepsia—Docetaxel—ovarian cancer	0.000277	0.00127	CcSEcCtD
Candesartan—Hepatitis—Doxorubicin—ovarian cancer	0.000276	0.00127	CcSEcCtD
Candesartan—Haemorrhage—Doxorubicin—ovarian cancer	0.000276	0.00127	CcSEcCtD
Candesartan—Pharyngitis—Doxorubicin—ovarian cancer	0.000274	0.00126	CcSEcCtD
Candesartan—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000273	0.00125	CcSEcCtD
Candesartan—Oedema peripheral—Doxorubicin—ovarian cancer	0.000272	0.00125	CcSEcCtD
Candesartan—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000271	0.00124	CcSEcCtD
Candesartan—Fatigue—Docetaxel—ovarian cancer	0.000271	0.00124	CcSEcCtD
Candesartan—Urethral disorder—Doxorubicin—ovarian cancer	0.000271	0.00124	CcSEcCtD
Candesartan—Asthenia—Paclitaxel—ovarian cancer	0.000266	0.00122	CcSEcCtD
Candesartan—Pruritus—Paclitaxel—ovarian cancer	0.000262	0.0012	CcSEcCtD
Candesartan—Mental disorder—Epirubicin—ovarian cancer	0.000261	0.0012	CcSEcCtD
Candesartan—Malnutrition—Epirubicin—ovarian cancer	0.00026	0.00119	CcSEcCtD
Candesartan—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000257	0.00118	CcSEcCtD
Candesartan—Diarrhoea—Paclitaxel—ovarian cancer	0.000254	0.00116	CcSEcCtD
Candesartan—Back pain—Epirubicin—ovarian cancer	0.000251	0.00115	CcSEcCtD
Candesartan—Body temperature increased—Docetaxel—ovarian cancer	0.000248	0.00114	CcSEcCtD
Candesartan—Abdominal pain—Docetaxel—ovarian cancer	0.000248	0.00114	CcSEcCtD
Candesartan—Dizziness—Paclitaxel—ovarian cancer	0.000245	0.00112	CcSEcCtD
Candesartan—Mental disorder—Doxorubicin—ovarian cancer	0.000242	0.00111	CcSEcCtD
Candesartan—Malnutrition—Doxorubicin—ovarian cancer	0.00024	0.0011	CcSEcCtD
Candesartan—Anaemia—Epirubicin—ovarian cancer	0.00024	0.0011	CcSEcCtD
Candesartan—Vomiting—Paclitaxel—ovarian cancer	0.000236	0.00108	CcSEcCtD
Candesartan—Rash—Paclitaxel—ovarian cancer	0.000234	0.00107	CcSEcCtD
Candesartan—Dermatitis—Paclitaxel—ovarian cancer	0.000233	0.00107	CcSEcCtD
Candesartan—Vertigo—Epirubicin—ovarian cancer	0.000233	0.00107	CcSEcCtD
Candesartan—Leukopenia—Epirubicin—ovarian cancer	0.000232	0.00107	CcSEcCtD
Candesartan—Back pain—Doxorubicin—ovarian cancer	0.000232	0.00107	CcSEcCtD
Candesartan—Headache—Paclitaxel—ovarian cancer	0.000232	0.00106	CcSEcCtD
Candesartan—Palpitations—Epirubicin—ovarian cancer	0.000229	0.00105	CcSEcCtD
Candesartan—Cough—Epirubicin—ovarian cancer	0.000227	0.00104	CcSEcCtD
Candesartan—Asthenia—Docetaxel—ovarian cancer	0.000225	0.00103	CcSEcCtD
Candesartan—Hypertension—Epirubicin—ovarian cancer	0.000224	0.00103	CcSEcCtD
Candesartan—Pruritus—Docetaxel—ovarian cancer	0.000222	0.00102	CcSEcCtD
Candesartan—Anaemia—Doxorubicin—ovarian cancer	0.000222	0.00102	CcSEcCtD
Candesartan—Arthralgia—Epirubicin—ovarian cancer	0.000221	0.00101	CcSEcCtD
Candesartan—Chest pain—Epirubicin—ovarian cancer	0.000221	0.00101	CcSEcCtD
Candesartan—Myalgia—Epirubicin—ovarian cancer	0.000221	0.00101	CcSEcCtD
Candesartan—Anxiety—Epirubicin—ovarian cancer	0.00022	0.00101	CcSEcCtD
Candesartan—Nausea—Paclitaxel—ovarian cancer	0.00022	0.00101	CcSEcCtD
Candesartan—Vertigo—Doxorubicin—ovarian cancer	0.000216	0.00099	CcSEcCtD
Candesartan—Leukopenia—Doxorubicin—ovarian cancer	0.000215	0.000986	CcSEcCtD
Candesartan—Diarrhoea—Docetaxel—ovarian cancer	0.000215	0.000985	CcSEcCtD
Candesartan—Palpitations—Doxorubicin—ovarian cancer	0.000212	0.000973	CcSEcCtD
Candesartan—Cough—Doxorubicin—ovarian cancer	0.00021	0.000961	CcSEcCtD
Candesartan—Dizziness—Docetaxel—ovarian cancer	0.000208	0.000952	CcSEcCtD
Candesartan—Thrombocytopenia—Epirubicin—ovarian cancer	0.000207	0.000951	CcSEcCtD
Candesartan—Hypertension—Doxorubicin—ovarian cancer	0.000207	0.000951	CcSEcCtD
Candesartan—ABCB1—lymph node—ovarian cancer	0.000207	0.00688	CbGeAlD
Candesartan—Tachycardia—Epirubicin—ovarian cancer	0.000207	0.000948	CcSEcCtD
Candesartan—Hyperhidrosis—Epirubicin—ovarian cancer	0.000205	0.000939	CcSEcCtD
Candesartan—Chest pain—Doxorubicin—ovarian cancer	0.000205	0.000938	CcSEcCtD
Candesartan—Myalgia—Doxorubicin—ovarian cancer	0.000205	0.000938	CcSEcCtD
Candesartan—Arthralgia—Doxorubicin—ovarian cancer	0.000205	0.000938	CcSEcCtD
Candesartan—Anxiety—Doxorubicin—ovarian cancer	0.000204	0.000934	CcSEcCtD
Candesartan—Vomiting—Docetaxel—ovarian cancer	0.0002	0.000916	CcSEcCtD
Candesartan—Rash—Docetaxel—ovarian cancer	0.000198	0.000908	CcSEcCtD
Candesartan—Hypotension—Epirubicin—ovarian cancer	0.000198	0.000908	CcSEcCtD
Candesartan—Dermatitis—Docetaxel—ovarian cancer	0.000198	0.000907	CcSEcCtD
Candesartan—Headache—Docetaxel—ovarian cancer	0.000197	0.000902	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000193	0.000885	CcSEcCtD
Candesartan—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000192	0.00088	CcSEcCtD
Candesartan—Tachycardia—Doxorubicin—ovarian cancer	0.000191	0.000877	CcSEcCtD
Candesartan—Paraesthesia—Epirubicin—ovarian cancer	0.00019	0.000872	CcSEcCtD
Candesartan—Hyperhidrosis—Doxorubicin—ovarian cancer	0.00019	0.000869	CcSEcCtD
Candesartan—Dyspnoea—Epirubicin—ovarian cancer	0.000189	0.000866	CcSEcCtD
Candesartan—Somnolence—Epirubicin—ovarian cancer	0.000188	0.000864	CcSEcCtD
Candesartan—Nausea—Docetaxel—ovarian cancer	0.000187	0.000856	CcSEcCtD
Candesartan—Dyspepsia—Epirubicin—ovarian cancer	0.000187	0.000855	CcSEcCtD
Candesartan—Hypotension—Doxorubicin—ovarian cancer	0.000183	0.00084	CcSEcCtD
Candesartan—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000183	0.000839	CcSEcCtD
Candesartan—Fatigue—Epirubicin—ovarian cancer	0.000183	0.000838	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000179	0.000819	CcSEcCtD
Candesartan—Paraesthesia—Doxorubicin—ovarian cancer	0.000176	0.000807	CcSEcCtD
Candesartan—Dyspnoea—Doxorubicin—ovarian cancer	0.000175	0.000801	CcSEcCtD
Candesartan—Somnolence—Doxorubicin—ovarian cancer	0.000174	0.000799	CcSEcCtD
Candesartan—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000173	0.000794	CcSEcCtD
Candesartan—Dyspepsia—Doxorubicin—ovarian cancer	0.000173	0.000791	CcSEcCtD
Candesartan—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000169	0.000776	CcSEcCtD
Candesartan—Fatigue—Doxorubicin—ovarian cancer	0.000169	0.000775	CcSEcCtD
Candesartan—Urticaria—Epirubicin—ovarian cancer	0.000168	0.000772	CcSEcCtD
Candesartan—Abdominal pain—Epirubicin—ovarian cancer	0.000168	0.000768	CcSEcCtD
Candesartan—Body temperature increased—Epirubicin—ovarian cancer	0.000168	0.000768	CcSEcCtD
Candesartan—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.00016	0.000735	CcSEcCtD
Candesartan—Urticaria—Doxorubicin—ovarian cancer	0.000156	0.000714	CcSEcCtD
Candesartan—Abdominal pain—Doxorubicin—ovarian cancer	0.000155	0.000711	CcSEcCtD
Candesartan—Body temperature increased—Doxorubicin—ovarian cancer	0.000155	0.000711	CcSEcCtD
Candesartan—Asthenia—Epirubicin—ovarian cancer	0.000152	0.000697	CcSEcCtD
Candesartan—Pruritus—Epirubicin—ovarian cancer	0.00015	0.000687	CcSEcCtD
Candesartan—Diarrhoea—Epirubicin—ovarian cancer	0.000145	0.000665	CcSEcCtD
Candesartan—Asthenia—Doxorubicin—ovarian cancer	0.000141	0.000645	CcSEcCtD
Candesartan—Dizziness—Epirubicin—ovarian cancer	0.00014	0.000642	CcSEcCtD
Candesartan—Pruritus—Doxorubicin—ovarian cancer	0.000139	0.000636	CcSEcCtD
Candesartan—Vomiting—Epirubicin—ovarian cancer	0.000135	0.000618	CcSEcCtD
Candesartan—Diarrhoea—Doxorubicin—ovarian cancer	0.000134	0.000615	CcSEcCtD
Candesartan—Rash—Epirubicin—ovarian cancer	0.000134	0.000613	CcSEcCtD
Candesartan—Dermatitis—Epirubicin—ovarian cancer	0.000133	0.000612	CcSEcCtD
Candesartan—Headache—Epirubicin—ovarian cancer	0.000133	0.000609	CcSEcCtD
Candesartan—Dizziness—Doxorubicin—ovarian cancer	0.00013	0.000594	CcSEcCtD
Candesartan—Nausea—Epirubicin—ovarian cancer	0.000126	0.000577	CcSEcCtD
Candesartan—Vomiting—Doxorubicin—ovarian cancer	0.000125	0.000572	CcSEcCtD
Candesartan—Rash—Doxorubicin—ovarian cancer	0.000124	0.000567	CcSEcCtD
Candesartan—Dermatitis—Doxorubicin—ovarian cancer	0.000124	0.000566	CcSEcCtD
Candesartan—Headache—Doxorubicin—ovarian cancer	0.000123	0.000563	CcSEcCtD
Candesartan—Nausea—Doxorubicin—ovarian cancer	0.000116	0.000534	CcSEcCtD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—ovarian cancer	8.65e-06	0.00545	CbGpPWpGaD
Candesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—AKT1—ovarian cancer	8.49e-06	0.00535	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—NME2—ovarian cancer	7.87e-06	0.00496	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—HSD17B6—ovarian cancer	7.77e-06	0.0049	CbGpPWpGaD
Candesartan—PTGS1—Biological oxidations—CYP1B1—ovarian cancer	7.27e-06	0.00458	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—ovarian cancer	7.21e-06	0.00454	CbGpPWpGaD
Candesartan—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	7.2e-06	0.00453	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—DLC1—ovarian cancer	6.61e-06	0.00416	CbGpPWpGaD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—TERT—ovarian cancer	6.21e-06	0.00391	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—CXCL8—ovarian cancer	5.63e-06	0.00355	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	5.61e-06	0.00353	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—BCL9—ovarian cancer	5.39e-06	0.00339	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CYTB—ovarian cancer	5.07e-06	0.0032	CbGpPWpGaD
Candesartan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ovarian cancer	4.77e-06	0.00301	CbGpPWpGaD
Candesartan—CYP2C8—Biological oxidations—CYP1B1—ovarian cancer	4.7e-06	0.00296	CbGpPWpGaD
Candesartan—CYP2C8—Metapathway biotransformation—CYP1B1—ovarian cancer	4.63e-06	0.00292	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PPP1CC—ovarian cancer	4.44e-06	0.00279	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—BRIP1—ovarian cancer	4.44e-06	0.00279	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—NME2—ovarian cancer	4.44e-06	0.00279	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—DOK1—ovarian cancer	4.26e-06	0.00268	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	4.13e-06	0.0026	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—ovarian cancer	4.09e-06	0.00258	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PPP1CC—ovarian cancer	4.01e-06	0.00252	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—ovarian cancer	3.92e-06	0.00247	CbGpPWpGaD
Candesartan—CYP2C9—Biological oxidations—CYP1B1—ovarian cancer	3.82e-06	0.00241	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	3.78e-06	0.00238	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ovarian cancer	3.78e-06	0.00238	CbGpPWpGaD
Candesartan—CYP2C9—Metapathway biotransformation—CYP1B1—ovarian cancer	3.77e-06	0.00238	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	3.76e-06	0.00237	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—ovarian cancer	3.73e-06	0.00235	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—ovarian cancer	3.73e-06	0.00235	CbGpPWpGaD
Candesartan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ovarian cancer	3.65e-06	0.0023	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	3.62e-06	0.00228	CbGpPWpGaD
Candesartan—AGTR1—G alpha (q) signalling events—PIK3CA—ovarian cancer	3.62e-06	0.00228	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	3.54e-06	0.00223	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—ovarian cancer	3.52e-06	0.00222	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—CXCL8—ovarian cancer	3.33e-06	0.0021	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—ovarian cancer	3.24e-06	0.00204	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	3.2e-06	0.00202	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—AQP3—ovarian cancer	3.19e-06	0.00201	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—CASP3—ovarian cancer	3.19e-06	0.00201	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IL2—ovarian cancer	3.19e-06	0.00201	CbGpPWpGaD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—ovarian cancer	3.13e-06	0.00197	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	3.1e-06	0.00195	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	3.07e-06	0.00193	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	3.06e-06	0.00193	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—IL6—ovarian cancer	3.05e-06	0.00192	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	3.04e-06	0.00192	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—HDAC6—ovarian cancer	3.04e-06	0.00191	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—PPP2R1A—ovarian cancer	2.99e-06	0.00189	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ovarian cancer	2.99e-06	0.00189	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—YAP1—ovarian cancer	2.97e-06	0.00187	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	2.95e-06	0.00186	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—CXCL8—ovarian cancer	2.88e-06	0.00181	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—NME2—ovarian cancer	2.86e-06	0.0018	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ovarian cancer	2.86e-06	0.0018	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CYTB—ovarian cancer	2.86e-06	0.0018	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.79e-06	0.00176	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—VEGFA—ovarian cancer	2.71e-06	0.00171	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—YAP1—ovarian cancer	2.69e-06	0.00169	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—XIAP—ovarian cancer	2.63e-06	0.00166	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SMARCA4—ovarian cancer	2.56e-06	0.00162	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—EREG—ovarian cancer	2.5e-06	0.00158	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—BRIP1—ovarian cancer	2.5e-06	0.00157	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PPP1CC—ovarian cancer	2.5e-06	0.00157	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—NME2—ovarian cancer	2.5e-06	0.00157	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	2.43e-06	0.00153	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—FASN—ovarian cancer	2.43e-06	0.00153	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	2.42e-06	0.00152	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—SLC5A5—ovarian cancer	2.39e-06	0.0015	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	2.36e-06	0.00149	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PGR—ovarian cancer	2.35e-06	0.00148	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—NME2—ovarian cancer	2.33e-06	0.00147	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—SLC2A1—ovarian cancer	2.3e-06	0.00145	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	2.23e-06	0.00141	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CYP1B1—ovarian cancer	2.21e-06	0.00139	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—PIK3CG—ovarian cancer	2.21e-06	0.00139	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PARP1—ovarian cancer	2.18e-06	0.00137	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—IL6ST—ovarian cancer	2.09e-06	0.00131	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—PIK3CG—ovarian cancer	2e-06	0.00126	CbGpPWpGaD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	2e-06	0.00126	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.98e-06	0.00125	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.98e-06	0.00125	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PPP2R1A—ovarian cancer	1.96e-06	0.00123	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—PIK3CD—ovarian cancer	1.94e-06	0.00122	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CYTB—ovarian cancer	1.85e-06	0.00116	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.82e-06	0.00115	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ABCB1—ovarian cancer	1.82e-06	0.00115	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.8e-06	0.00114	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—TYMS—ovarian cancer	1.79e-06	0.00113	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PPP2R1A—ovarian cancer	1.77e-06	0.00111	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—PIK3CD—ovarian cancer	1.76e-06	0.00111	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	1.74e-06	0.00109	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—PIK3CB—ovarian cancer	1.69e-06	0.00107	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—YAP1—ovarian cancer	1.68e-06	0.00106	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.66e-06	0.00104	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CXCL8—ovarian cancer	1.63e-06	0.00102	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.61e-06	0.00102	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—BRIP1—ovarian cancer	1.61e-06	0.00102	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PPP1CC—ovarian cancer	1.61e-06	0.00102	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.61e-06	0.00102	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CYTB—ovarian cancer	1.61e-06	0.00101	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	1.61e-06	0.00101	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	1.57e-06	0.000992	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.56e-06	0.000982	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—IL2—ovarian cancer	1.55e-06	0.000978	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—PIK3CB—ovarian cancer	1.54e-06	0.000967	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.53e-06	0.000965	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.52e-06	0.000956	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CYTB—ovarian cancer	1.5e-06	0.000946	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.48e-06	0.000932	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CXCL8—ovarian cancer	1.48e-06	0.000929	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.47e-06	0.000925	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.46e-06	0.000918	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CAV1—ovarian cancer	1.44e-06	0.000907	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—IL2—ovarian cancer	1.41e-06	0.000888	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—BRIP1—ovarian cancer	1.41e-06	0.000885	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PPP1CC—ovarian cancer	1.41e-06	0.000885	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TERT—ovarian cancer	1.41e-06	0.000885	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—FASN—ovarian cancer	1.37e-06	0.00086	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—SLC5A5—ovarian cancer	1.34e-06	0.000846	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.34e-06	0.000842	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—BRIP1—ovarian cancer	1.31e-06	0.000827	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PPP1CC—ovarian cancer	1.31e-06	0.000827	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PIK3CG—ovarian cancer	1.31e-06	0.000826	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CAV1—ovarian cancer	1.3e-06	0.000819	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—SLC2A1—ovarian cancer	1.3e-06	0.000817	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.27e-06	0.0008	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.26e-06	0.000796	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—ESR1—ovarian cancer	1.25e-06	0.000789	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CYP1B1—ovarian cancer	1.24e-06	0.000783	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL6ST—ovarian cancer	1.23e-06	0.000776	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.23e-06	0.000774	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.2e-06	0.000758	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.2e-06	0.000757	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—APC—ovarian cancer	1.18e-06	0.000746	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PIK3CG—ovarian cancer	1.18e-06	0.000746	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—NRAS—ovarian cancer	1.18e-06	0.000746	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.18e-06	0.000741	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PIK3CD—ovarian cancer	1.15e-06	0.000726	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.14e-06	0.000716	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—MAPK3—ovarian cancer	1.13e-06	0.000714	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PPP2R1A—ovarian cancer	1.1e-06	0.000695	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.1e-06	0.000691	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—YAP1—ovarian cancer	1.08e-06	0.000682	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—MAPK1—ovarian cancer	1.08e-06	0.000679	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—EGFR—ovarian cancer	1.08e-06	0.000679	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.07e-06	0.000675	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	1.04e-06	0.000657	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PIK3CD—ovarian cancer	1.04e-06	0.000656	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—PIK3CA—ovarian cancer	1.03e-06	0.000649	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ABCB1—ovarian cancer	1.02e-06	0.000645	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—KRAS—ovarian cancer	1.02e-06	0.000642	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.01e-06	0.000636	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—TYMS—ovarian cancer	1.01e-06	0.000634	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PIK3CB—ovarian cancer	1e-06	0.000633	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	9.57e-07	0.000603	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—YAP1—ovarian cancer	9.43e-07	0.000594	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	9.42e-07	0.000593	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—PIK3CA—ovarian cancer	9.36e-07	0.00059	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—ERBB2—ovarian cancer	9.19e-07	0.000579	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MTOR—ovarian cancer	9.07e-07	0.000571	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PIK3CB—ovarian cancer	9.07e-07	0.000571	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—FASN—ovarian cancer	8.82e-07	0.000556	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—YAP1—ovarian cancer	8.81e-07	0.000555	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CXCL8—ovarian cancer	8.72e-07	0.000549	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	8.72e-07	0.000549	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PTEN—ovarian cancer	8.68e-07	0.000547	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—SLC5A5—ovarian cancer	8.68e-07	0.000547	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—HRAS—ovarian cancer	8.66e-07	0.000546	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	8.53e-07	0.000537	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CDKN1B—ovarian cancer	8.51e-07	0.000536	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—AKT1—ovarian cancer	8.42e-07	0.00053	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—SLC2A1—ovarian cancer	8.38e-07	0.000528	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CASP3—ovarian cancer	8.34e-07	0.000526	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL2—ovarian cancer	8.33e-07	0.000525	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—IL6—ovarian cancer	8.29e-07	0.000522	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	8.21e-07	0.000517	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCND1—ovarian cancer	8.12e-07	0.000512	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CAV1—ovarian cancer	8.11e-07	0.000511	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CTNNB1—ovarian cancer	8.04e-07	0.000507	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CYP1B1—ovarian cancer	8.04e-07	0.000506	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MMP9—ovarian cancer	7.89e-07	0.000497	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PTEN—ovarian cancer	7.84e-07	0.000494	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.75e-07	0.000488	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—FASN—ovarian cancer	7.69e-07	0.000484	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	7.66e-07	0.000483	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—AKT1—ovarian cancer	7.65e-07	0.000482	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SLC5A5—ovarian cancer	7.56e-07	0.000476	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PIK3CG—ovarian cancer	7.38e-07	0.000465	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SLC2A1—ovarian cancer	7.3e-07	0.00046	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—FASN—ovarian cancer	7.18e-07	0.000452	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	7.13e-07	0.000449	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	7.09e-07	0.000447	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—VEGFA—ovarian cancer	7.08e-07	0.000446	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SLC5A5—ovarian cancer	7.06e-07	0.000445	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—STAT3—ovarian cancer	7.01e-07	0.000442	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CYP1B1—ovarian cancer	7e-07	0.000441	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NRAS—ovarian cancer	6.99e-07	0.00044	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SLC2A1—ovarian cancer	6.82e-07	0.00043	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MAPK3—ovarian cancer	6.7e-07	0.000422	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.68e-07	0.000421	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ABCB1—ovarian cancer	6.62e-07	0.000417	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CYP1B1—ovarian cancer	6.54e-07	0.000412	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MYC—ovarian cancer	6.51e-07	0.00041	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—TYMS—ovarian cancer	6.5e-07	0.000409	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PIK3CD—ovarian cancer	6.49e-07	0.000409	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MAPK1—ovarian cancer	6.37e-07	0.000401	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—EGFR—ovarian cancer	6.37e-07	0.000401	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PPP2R1A—ovarian cancer	6.21e-07	0.000391	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PIK3CA—ovarian cancer	6.12e-07	0.000386	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—KRAS—ovarian cancer	6.02e-07	0.000379	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	5.8e-07	0.000365	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.77e-07	0.000364	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—TYMS—ovarian cancer	5.66e-07	0.000357	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PIK3CB—ovarian cancer	5.66e-07	0.000356	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PIK3CA—ovarian cancer	5.53e-07	0.000348	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ABCB1—ovarian cancer	5.39e-07	0.000339	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TP53—ovarian cancer	5.35e-07	0.000337	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—TYMS—ovarian cancer	5.29e-07	0.000333	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CAV1—ovarian cancer	5.24e-07	0.00033	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—HRAS—ovarian cancer	5.12e-07	0.000322	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5e-07	0.000315	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—AKT1—ovarian cancer	5e-07	0.000315	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL6—ovarian cancer	4.9e-07	0.000308	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PTEN—ovarian cancer	4.89e-07	0.000308	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PIK3CG—ovarian cancer	4.77e-07	0.0003	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CAV1—ovarian cancer	4.56e-07	0.000287	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—AKT1—ovarian cancer	4.52e-07	0.000285	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CAV1—ovarian cancer	4.26e-07	0.000268	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PIK3CD—ovarian cancer	4.19e-07	0.000264	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PIK3CG—ovarian cancer	4.16e-07	0.000262	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.07e-07	0.000256	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PIK3CG—ovarian cancer	3.88e-07	0.000245	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PIK3CB—ovarian cancer	3.66e-07	0.00023	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PIK3CD—ovarian cancer	3.65e-07	0.00023	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PIK3CA—ovarian cancer	3.45e-07	0.000217	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PIK3CD—ovarian cancer	3.41e-07	0.000215	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PIK3CB—ovarian cancer	3.18e-07	0.000201	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PTEN—ovarian cancer	3.16e-07	0.000199	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PIK3CB—ovarian cancer	2.97e-07	0.000187	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—AKT1—ovarian cancer	2.82e-07	0.000177	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PTEN—ovarian cancer	2.75e-07	0.000173	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PTEN—ovarian cancer	2.57e-07	0.000162	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PIK3CA—ovarian cancer	2.23e-07	0.00014	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.94e-07	0.000122	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—AKT1—ovarian cancer	1.82e-07	0.000115	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.81e-07	0.000114	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—AKT1—ovarian cancer	1.59e-07	9.99e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—AKT1—ovarian cancer	1.48e-07	9.33e-05	CbGpPWpGaD
